To reach out to more people with affordable and quality medicines, Wings launched Novitas Healthcare as a separate SBU in 2010. Novitas is a result of an employee-driven idea and was incubated inside the organization for over one year before it recognized itself as one among the five fully-owned SBU's of Wings.
Since inception, Novitas has imbibed the parent company's values and culture of providing innovative and affordable pharmaceutical products. The divisions focus has been to compete in Branded Generics category and today Novitas is reckoned as one of the key players in this segment.
The division has a product portfolio of over 130 products ranging from anti-infective to pain-management and diabetic solutions to derma care. With a national presence Wings is proud to share that the Novitas portfolio has touched over 70 million lives and has set itself a target of increasing this reach to touch over a 150 million lives in the near future.